| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jun-ichi Satoh, Shinya Obayashi, Tamako Misawa, Hiroko Tabunoki, Takashi Yamamura, Kunimasa Arima, Hidehiko Konn. Neuromyelitis optica/Devic's disease: gene expression profiling of brain lesions. Neuropathology : official journal of the Japanese Society of Neuropathology. vol 28. issue 6. 2009-01-28. PMID:18410276. |
neuromyelitis optica (nmo), also known as devic's disease, is an inflammatory demyelinating disease that affects selectively the optic nerves and the spinal cord, possibly mediated by an immune mechanism distinct from that of multiple sclerosis (ms). |
2009-01-28 |
2023-08-12 |
Not clear |
| Denis Bernardi Bichuetti, René Leandro Magalhães Rivero, Daniel May Oliveira, Nilton Amorin de Souza, Nitamar Abdala, Enedina Maria Lobato Oliveira, Alberto Alain Gabba. Neuromyelitis optica: brain abnormalities in a Brazilian cohort. Arquivos de neuro-psiquiatria. vol 66. issue 1. 2009-01-05. PMID:18392403. |
neuromyelitis optica (nmo) is a demyelinating disease consisting of relapsing-remitting optic neuritis and myelitis with a more severe course than multiple sclerosis. |
2009-01-05 |
2023-08-12 |
Not clear |
| Marco Aurélio Lana-Peixot. Devic's neuromyelitis optica: a critical review. Arquivos de neuro-psiquiatria. vol 66. issue 1. 2009-01-05. PMID:18392436. |
devic's neuromyelitis optica (nmo) is an idiopathic inflammatory demyelinating and necrotizing disease characterized by predominant involvement of the optic nerves and spinal cord. |
2009-01-05 |
2023-08-12 |
Not clear |
| B Weinstock-Guttman, C Miller, Ea Yeh, M Stosic, M Umhauer, N Batra, F Munschauer, R Zivadinov, M Ramanatha. Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). vol 14. issue 8. 2008-12-31. PMID:18573816. |
to determine whether neuromyelitis optica (nmo) immunoglobulin (igg) antibody status in nmo/devic's disease patients followed prospectively is persistent or can change relative to the clinical status and/or response to therapy. |
2008-12-31 |
2023-08-12 |
Not clear |
| Jun-ichi Kir. Neuromyelitis optica and asian phenotype of multiple sclerosis. Annals of the New York Academy of Sciences. vol 1142. 2008-12-30. PMID:18990121. |
multiple sclerosis (ms) is a demyelinating disease of the central nervous system (cns), whereas neuromyelitis optica (nmo) is an inflammatory disease of the cns selectively affecting the optic nerves and spinal cord. |
2008-12-30 |
2023-08-12 |
Not clear |
| Vesna V Brinar, Charles M Pose. Disseminated encephalomyelitis in adults. Clinical neurology and neurosurgery. vol 110. issue 9. 2008-12-16. PMID:18703274. |
some aspects of dem overlap with neuromyelitis optica (nmo), another demyelination disease of cns that was for a long time regarded as part of the ms spectrum, until discovery of the aquaporin-4 antibodies, claimed to be specific for nmo. |
2008-12-16 |
2023-08-12 |
Not clear |
| S Jarius, F Aboul-Enein, P Waters, B Kuenz, A Hauser, T Berger, W Lang, M Reindl, A Vincent, W Kristoferitsc. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain : a journal of neurology. vol 131. issue Pt 11. 2008-12-12. PMID:18945724. |
neuromyelitis optica (nmo) is a severe inflammatory cns disorder of putative autoimmune aetiology, which predominantly affects the spinal cord and optic nerves. |
2008-12-12 |
2023-08-12 |
human |
| Anu Jacob, Brian G Weinshenker, Ivo Violich, Nancy McLinskey, Lauren Krupp, Robert J Fox, Dean M Wingerchuk, Mike Boggild, Cris S Constantinescu, Aaron Miller, Tracy De Angelis, Marcelo Matiello, Bruce A C Cre. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Archives of neurology. vol 65. issue 11. 2008-12-10. PMID:18779415. |
neuromyelitis optica (nmo) is an uncommon, life-threatening inflammatory demyelinating disorder. |
2008-12-10 |
2023-08-12 |
Not clear |
| Shannon R Hinson, Shanu F Roemer, Claudia F Lucchinetti, James P Fryer, Thomas J Kryzer, Jayne L Chamberlain, Charles L Howe, Sean J Pittock, Vanda A Lenno. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. The Journal of experimental medicine. vol 205. issue 11. 2008-12-10. PMID:18838545. |
neuromyelitis optica (nmo)-immunoglobulin g (igg) is a clinically validated serum biomarker that distinguishes relapsing central nervous system (cns) inflammatory demyelinating disorders related to nmo from multiple sclerosis. |
2008-12-10 |
2023-08-12 |
Not clear |
| Y Li, P Xie, F Lv, J Mu, Q Li, Q Yang, M Hu, H Tang, J Y. Brain magnetic resonance imaging abnormalities in neuromyelitis optica. Acta neurologica Scandinavica. vol 118. issue 4. 2008-11-18. PMID:18384459. |
brain abnormalities in neuromyelitis optica (nmo) attracted much attention. |
2008-11-18 |
2023-08-12 |
Not clear |
| P Waters, Angela Vincen. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. International MS journal. vol 15. issue 3. 2008-11-18. PMID:18808744. |
neuromyelitis optica (nmo) is a severe inflammatory demyelinating disease that predominantly affects the optic nerve and spinal cord. |
2008-11-18 |
2023-08-12 |
Not clear |
| M Bradl, Dr Hans Lassman. Anti-aquaporin-4 antibodies in neuromyelitis optica: how to prove their pathogenetic relevance? International MS journal. vol 15. issue 3. 2008-11-18. PMID:18812056. |
the discovery of a specific autoantibody response in neuromyelitis optica (nmo) patients, which selectively targets astrocytic end feet at the glia limitans1 and which is directed against the water channel aquaporin-4 (aqp-4)2 was a milestone in defining this disease entity and profoundly changed our view regarding its pathogenesis.3 indirect evidence, coming from clinical observations and pathology strongly suggest that these autoantibodies play a major role in driving the disease process. |
2008-11-18 |
2023-08-12 |
Not clear |
| Bruce Cre. Neuromyelitis optica: diagnosis, pathogenesis, and treatment. Current neurology and neuroscience reports. vol 8. issue 5. 2008-10-16. PMID:18713580. |
although the co-occurrence of myelitis and optic neuritis that characterizes neuromyelitis optica (nmo) was recognized over a century ago, distinguishing nmo from multiple sclerosis relied solely on clinical criteria until recently. |
2008-10-16 |
2023-08-12 |
Not clear |
| S Jarius, D Franciotta, R Bergamaschi, S Rauer, K P Wandinger, H F Petereit, M Maurer, H Tumani, A Vincent, P Eichhorn, B Wildemann, M Wick, R Volt. Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. Journal of neurology, neurosurgery, and psychiatry. vol 79. issue 10. 2008-10-15. PMID:18270237. |
a polyspecific, intrathecal humoral immune response against neurotropic viruses such as measles, rubella and varicella zoster virus (mrz reaction, mrzr) is present in 80-100% of patients with multiple sclerosis (ms), but has not to date been evaluated in patients with neuromyelitis optica (nmo). |
2008-10-15 |
2023-08-12 |
Not clear |
| Harold Merle, Stéphane Olindo, Angélique Donnio, Raymond Richer, Didier Smadja, Philippe Cabr. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Investigative ophthalmology & visual science. vol 49. issue 10. 2008-10-10. PMID:18614811. |
to measure the thickness of retinal peripapillary nerve fibers throughout the course of neuromyelitis optica (nmo). |
2008-10-10 |
2023-08-12 |
Not clear |
| David J Graber, Michael Levy, Douglas Kerr, William F Wad. Neuromyelitis optica pathogenesis and aquaporin 4. Journal of neuroinflammation. vol 5. 2008-09-22. PMID:18510734. |
neuromyelitis optica (nmo) is a severe, debilitating human disease that predominantly features immunopathology in the optic nerves and the spinal cord. |
2008-09-22 |
2023-08-12 |
human |
| J-S Wu, M-N Zhang, W M Carroll, A G Kermod. Characterisation of the spectrum of demyelinating disease in Western Australia. Journal of neurology, neurosurgery, and psychiatry. vol 79. issue 9. 2008-09-03. PMID:18356258. |
the diversity of multiple sclerosis (ms) and the nosology of the conventional form of ms (cms), optic-spinal ms (osms) and neuromyelitis optica (nmo) have been subject to controversy. |
2008-09-03 |
2023-08-12 |
human |
| T Takahashi, I Miyazawa, T Misu, R Takano, I Nakashima, K Fujihara, M Tobita, Y Itoyam. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. Journal of neurology, neurosurgery, and psychiatry. vol 79. issue 9. 2008-09-03. PMID:18420727. |
intractable hiccup and nausea (ihn) are unique symptoms in neuromyelitis optica (nmo). |
2008-09-03 |
2023-08-12 |
Not clear |
| C Cassinotto, J Joux, N Chausson, D Smadja, P Cabr. [Failure of rituximab in relapsing neuromyelitis optica: case report with two-year prospective follow-up]. Revue neurologique. vol 164. issue 4. 2008-08-08. PMID:18439934. |
neuromyelitis optica (devic's disease, nmo) is an inflammatory disease of the central nervous system preferentially involving the spinal cord and optic nerves in either a monophasic or relapsing-remitting course. |
2008-08-08 |
2023-08-12 |
Not clear |
| Sven Jarius, Friedemann Paul, Diego Franciotta, Patrick Waters, Frauke Zipp, Reinhard Hohlfeld, Angela Vincent, Brigitte Wildeman. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nature clinical practice. Neurology. vol 4. issue 4. 2008-08-04. PMID:18334978. |
neuromyelitis optica (nmo) is a rare cns inflammatory disorder that predominantly affects the optic nerves and spinal cord. |
2008-08-04 |
2023-08-12 |
Not clear |